MicroRNA and cancer - A brief overview

Advances in Biological Regulation

Volumn 57, Issue , 2015, Pages 1-9

  Acunzo, Mario ^a   Romano, Giulia ^a   Wernicke, Dorothee ^a   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Biomarker; Cancer; MicroRNA

Indexed keywords

MICRORNA; RNA;

ANIMAL; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; RNA, NEOPLASM;

EID: 84920875136     PISSN: 22124926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbior.2014.09.013     Document Type: Review

References (97)

1. Acunzo M., Romano G., Palmieri D., Lagana A., Garofalo M., Balatti V., et al. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proc Natl Acad Sci U S A 2013, 110:8573-8578.
2. Acunzo M., Visone R., Romano G., Veronese A., Lovat F., Palmieri D., et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 2012, 31:634-642.
3. Adam L., Zhong M., Choi W., Qi W., Nicoloso M., Arora A., et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res Off J Am Assoc Cancer Res 2009, 15:5060-5072.
4. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011, 108:5003-5008.
5. Bader A.G., Brown D., Stoudemire J., Lammers P. Developing therapeutic microRNAs for cancer. Gene Ther 2011, 18:1121-1126.
6. Bader A.G., Brown D., Winkler M. The promise of microRNA replacement therapy. Cancer Res 2010, 70:7027-7030.
7. Bao L., Hazari S., Mehra S., Kaushal D., Moroz K., Dash S. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 2012, 180:2490-2503.
8. Baranwal S., Alahari S.K. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010, 126:1283-1290.
9. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
10. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
11. Boehm M., Slack F.J. MicroRNA control of lifespan and metabolism. Cell Cycle 2006, 5:837-840.
12. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
13. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004, 101:2999-3004.
14. Caramuta S., Egyhazi S., Rodolfo M., Witten D., Hansson J., Larsson C., et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. JInvestig Dermatol 2010, 130:2062-2070.
15. Carleton M., Cleary M.A., Linsley P.S. MicroRNAs and cell cycle regulation. Cell Cycle 2007, 6:2127-2132.
16. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
17. Chin L.J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., et al. ASNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res 2008, 68:8535-8540.
18. Choi K.Y., Silvestre O.F., Huang X.L., Hida N., Liu G., Ho D.N., et al. Ananoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and invivo. Nat Protoc 2014, 9:1900-1915.
19. Corney D.C., Flesken-Nikitin A., Godwin A.K., Wang W., Nikitin A.Y. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007, 67:8433-8438.
20. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 2006, 103:7024-7029.
21. Creemers E.E., Tijsen A.J., Pinto Y.M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res 2012, 110:483-495.
22. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10:704-714.
23. Darido C., Georgy S.R., Wilanowski T., Dworkin S., Auden A., Zhao Q., et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 2011, 20:635-648.
24. Di Leva G., Garofalo M., Croce C.M. MicroRNAs in cancer. Annu Rev Pathol Mech 2014, 9:287-314.
25. Diederichs S., Haber D.A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007, 131:1097-1108.
26. Ding C., Li C., Wang H., Li B., Guo Z. AmiR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer. OncoTargets Ther 2013, 6:877-881.
27. Djuranovic S., Nahvi A., Green R. Aparsimonious model for gene regulation by miRNAs. Science 2011, 331:550-553.
28. Dogini D.B., Pascoal V.D.B., Avansini S.H., Vieira A.S., Pereira T.C., Lopes-Cendes I. The new world of RNAs. Genet Mol Biol 2014, 37:285-293.
29. Drusco A., Nuovo G.J., Zanesi N., Di Leva G., Pichiorri F., Volinia S., et al. MicroRNA profiles discriminate among colon cancer metastasis. PLoS One 2014, 9:e96670.
30. Du W.W., Yang B.B., Yang B.L., Deng Z., Fang L., Shan S.W., et al. Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy. PLoS One 2011, 6:e26396.
31. Esteller M. Epigenetics in cancer. NEngl J Med 2008, 358:1148-1159.
32. Fabbri M., Calore F., Paone A., Galli R., Calin G.A. Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol 2013, 754:137-148.
33. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007, 104:15805-15810.
34. Fabian M.R., Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012, 19:586-593.
35. Garofalo M., Di Leva G., Romano G., Nuovo G., Suh S.S., Ngankeu A., et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009, 16:498-509.
36. Giovannetti E., Funel N., Peters G.J., Del Chiaro M., Erozenci L.A., Vasile E., et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010, 70:4528-4538.
37. Hamano R., Hideshi I., Miyta H., Doky Y., Mori M. Role of microRNAs in solid tumors. JNucleic Acids Investig 2011, 2:2e.
38. Han J., Lee Y., Yeom K.H., Kim Y.K., Jin H., Kim V.N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004, 18:3016-3027.
39. Harfe B.D. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005, 15:410-415.
40. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. AmicroRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
41. Heinrich E.M., Dimmeler S. MicroRNAs and stem cells control of pluripotency, reprogramming, and lineage commitment. Circ Res 2012, 110:1014-1022.
42. Hwang H.W., Mendell J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006, 94:776-780.
43. Iorio M.V., Croce C.M. microRNA involvement in human cancer. Carcinogenesis 2012, 33:1126-1133.
44. Jansson M.D., Lund A.H. MicroRNA and cancer. Mol Oncol 2012, 6:590-610.
45. Jin P., Alisch R.S., Warren S.T. RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 2004, 6:1048-1053.
46. Jovanovic M., Hengartner M.O. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25:6176-6187.
47. Kim V.N. MicroRNA precursors in motion: exportin-5 mediates their nuclear export. Trends Cell Biol 2004, 14:156-159.
48. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139.
49. Krutzfeldt J., Kuwajima S., Braich R., Rajeev K.G., Pena J., Tuschl T., et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007, 35:2885-2892.
50. Lagana A., Acunzo M., Romano G., Pulvirenti A., Veneziano D., Cascione L., et al. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs. Nucleic Acids Res 2014, 42:5416-5425.
51. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
52. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
53. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
54. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
55. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
56. Li H., Yang B.B. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 2012, 3:1653-1668.
57. Li X.H., Zhang Y., Zhang Y.F., Ding J., Wu K.C., Fan D.M. Survival prediction of gastric cancer by a seven-microRNA signature. Gut 2010, 59:579-585.
58. Liang Z., Li Y., Huang K., Wagar N., Shim H. Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN. Pharm Res 2011, 28:3091-3100.
59. Lu J., Deutsch C. Folding zones inside the ribosomal exit tunnel. Nat Struct Mol Biol 2005, 12:1123-1129.
60. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
61. Ma J., Dong C., Ji C. MicroRNA and drug resistance. Cancer Gene Ther 2010, 17:523-531.
62. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an invivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
63. Merritt W.M., Lin Y.G., Han L.Y., Kamat A.A., Spannuth W.A., Schmandt R., et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. NEngl J Med 2008, 359:2641-2650.
64. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
65. Pencheva N., Tavazoie S.F. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 2013, 15:546-554.
66. Pernaute B., Spruce T., Rodriguez T.A., Manzanares M. MiRNA-mediated regulation of cell signaling and homeostasis in the early mouse embryo. Cell Cycle 2011, 10:584-591.
67. Peter M.E. Regulating cancer stem cells the miR way. Cell Stem Cell 2010, 6:4-6.
68. Png K.J., Halberg N., Yoshida M., Tavazoie S.F. AmicroRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 2012, 481:190-194.
69. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X.S., MacDonald P.E., et al. Apancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
70. Rabinowits G., Gercel-Taylor C., Day J.M., Taylor D.D., Kloecker G.H. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009, 10:42-46.
71. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
72. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004, 14:1902-1910.
73. Romano G., Acunzo M., Garofalo M., Di Leva G., Cascione L., Zanca C., et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A 2012, 109:16570-16575.
74. Rosenfeld N., Aharonov R., Meiri E., Rosenwald S., Spector Y., Zepeniuk M., et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008, 26:462-469.
75. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9:435-443.
76. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA J Am Med Assoc 2008, 299:425-436.
77. Scholl V., Hassan R., Zalcberg I.R. miRNA-451: a putative predictor marker of Imatinib therapy response in chronic myeloid leukemia. Leuk Res 2012, 36:119-121.
78. Schwarzenbach H., Nishida N., Calin G.A., Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 2014, 11:145-156.
79. Seike M., Goto A., Okano T., Bowman E.D., Schetter A.J., Horikawa I., et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009, 106:12085-12090.
80. Shi G.H., Ye D.W., Yao X.D., Zhang S.L., Dai B., Zhang H.L., et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells. Acta Pharmacol Sin 2010, 31:867-873.
81. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
82. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21.
83. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
84. Vecchione A., Belletti B., Lovat F., Volinia S., Chiappetta G., Giglio S., et al. AmicroRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A 2013, 110:9845-9850.
85. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433.
86. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. AmicroRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261.
87. Wang Y.S., Wang Y.H., Xia H.P., Zhou S.W., Schmid-Bindert G., Zhou C.C. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. Asian Pac J Cancer Prev APJCP 2012, 13:255-260.
88. Wang Z. The guideline of the design and validation of MiRNA mimics. Methods Mol Biol 2011, 676:211-223.
89. Weiland M., Gao X.H., Zhou L., Mi Q.S. Small RNAs have a large impact circulating microRNAs as biomarkers for human diseases. RNA Biol 2012, 9:850-859.
90. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene Lin-14 by Lin-4 mediates temporal pattern-formation in C. elegans. Cell 1993, 75:855-862.
91. Wynendaele J., Bohnke A., Leucci E., Nielsen S.J., Lambertz I., Hammer S., et al. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res 2010, 70:9641-9649.
92. Zernecke A., Bidzhekov K., Noels H., Shagdarsuren E., Gan L., Denecke B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
93. Zhang L.Y., Ho-Fun Lee V., Wong A.M., Kwong D.L., Zhu Y.H., Dong S.S., et al. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 2013, 34:454-463.
94. Zhou X., Ren Y., Moore L., Mei M., You Y., Xu P., et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Investig J Tech Methods Pathol 2010, 90:144-155.
95. Zhu H., Wu H., Liu X., Evans B.R., Medina D.J., Liu C.G., et al. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008, 76:582-588.
96. Zhu X., Li H., Long L., Hui L., Chen H., Wang X., et al. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim Biophys Sin 2012, 44:519-526.
97. Ziebarth J.D., Cook M.N., Wang X., Williams R.W., Lu L., Cui Y. Treatment- and population-dependent activity patterns of behavioral and expression QTLs. PLoS One 2012, 7:e31805.